• No results found

Si/sup +/ implant

Implant survivorship analysis after minimally invasive sacroiliac joint fusion using the iFuse Implant System®

Implant survivorship analysis after minimally invasive sacroiliac joint fusion using the iFuse Implant System<sup>&reg;</sup>

... our ability to determine whether any other patient factors (eg, body mass index, sacral anatomy, comorbidities) may affect the risk of revision. Although only a small number of known revision surgeries could not be ...

8

The pharmacokinetics and safety of an intraoperative bupivacaine-collagen implant (XaraColl&reg;) for postoperative analgesia in women following total abdominal hysterectomy

The pharmacokinetics and safety of an intraoperative bupivacaine-collagen implant (XaraColl<sup>&reg;</sup>) for postoperative analgesia in women following total abdominal hysterectomy

... Another salient feature of the pharmacokinetics was the apparent double peak in the bupivacaine concentration-time profile. This was observed in the majority of individual patients, with the first peak generally ...

9

The KineSpring&reg; Knee Implant System: an implantable joint-unloading prosthesis for treatment of medial knee osteoarthritis

The KineSpring<sup>&reg;</sup> Knee Implant System: an implantable joint-unloading prosthesis for treatment of medial knee osteoarthritis

... KineSpring implant including direct testing of the fixation system under cyclic and static ...the implant constructs due to the cyclic com- pression of the spring after ...

8

Download
			
			
				Download PDF

Download Download PDF

... Objective: the purpose of this multicenter retrospective study was to report on survival, success, and complication rates in monolithic zirconia restorations on teeth and implants. Materials and Methods: data on 671 ...

7

Investigating the Influence of Interface and Vacancy Defects on the Growth of Silicon Quantum Dots in SiO2

Investigating the Influence of Interface and Vacancy Defects on the Growth of Silicon Quantum Dots in SiO2

... to implant more area without moving the sample stage the beam passes through a raster scanner before reaching the sample ...desired implant area, up to 5cm 2 is ...non-uniform implant therefore the ...

54

Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex&reg;) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion

Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex<sup>&reg;</sup>) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion

... measurable, improvement in vision with a single injection, and repeat injection is usually necessary for most CRVO patients. That does not appear to be the case for BRVO patients where the natural history, as well as ...

7

A novel intravitreal fluocinolone acetonide implant (Iluvien&reg;) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series

A novel intravitreal fluocinolone acetonide implant (Iluvien<sup>&reg;</sup>) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series

... defined by a duration of the disease of 3 years. In this typically difficult-to-treat patient population, a gain of 15 letters was achieved by 34.0% of patients treated with FAc 0.2 µ g/d versus 13.4 in the sham group. ...

11

Clinical utility of intravitreal fluocinolone acetonide (Iluvien&reg;) implant in the management of patients with chronic diabetic macular edema: a review of the current literature

Clinical utility of intravitreal fluocinolone acetonide (Iluvien<sup>&reg;</sup>) implant in the management of patients with chronic diabetic macular edema: a review of the current literature

... intravitreal implant has been shown in pivotal clinical trials to be efficacious for the treatment of DME and has been approved in many countries for use in patients who have not responded to first-line ...FA ...

8

Clinical evaluation of XaraColl&reg;, a bupivacaine-collagen implant, for postoperative analgesia in two multicenter, randomized, double-blind, placebo-controlled pilot studies

Clinical evaluation of XaraColl<sup>&reg;</sup>, a bupivacaine-collagen implant, for postoperative analgesia in two multicenter, randomized, double-blind, placebo-controlled pilot studies

... bupivacaine-collagen implant, significantly reduces pain and use of opioid medication over at least 48 hours after hernioplasty, as based on two independent pilot studies performed at safe and well toler- ated ...

9

Oxidized porous silicon for localized formation of SOI active regions

Oxidized porous silicon for localized formation of SOI active regions

... nm. However once the porous silicon reaches the p-buried region there is formation selectivity which is driven by the higher boron (hole) concentration in the p-buried region and the tendency for a thin lightly doped ...

82

Analysis of postmarket complaints database for the iFuse SI Joint Fusion System&reg;: a minimally invasive treatment for degenerative sacroiliitis and sacroiliac joint disruption

Analysis of postmarket complaints database for the iFuse SI Joint Fusion System<sup>&reg;</sup>: a minimally invasive treatment for degenerative sacroiliitis and sacroiliac joint disruption

... Symptom recurrence was a rare (0.6%) complication. The iFuse implants were designed to resist rotational and pullout forces, with biomechanical testing confirming exponentially greater resistance to shear and bending ...

8

The activL&reg; Artificial Disc: a next-generation motion-preserving implant for chronic lumbar discogenic pain

The activL<sup>&reg;</sup> Artificial Disc: a next-generation motion-preserving implant for chronic lumbar discogenic pain

... Patients are generally permitted to ambulate on the day of surgery, as tolerated, with an elastic bandage or lumbosacral orthosis to support the abdominal musculature. Patients are advised to avoid hyperextension for 3 ...

10

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN&reg;) and Follow-Up Considerations/Recommendations

<p>Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN<sup>&reg;</sup>) and Follow-Up Considerations/Recommendations</p>

... In fl ammatory processes play an important role in DR pathogenesis. 28–30 In DME patients, levels of in fl amma- tory cytokines, VEGF, as well as the important modulator of angiogenesis, angiopoietin-2, are signi fi cantly ...

17

Successful two-stage revision of a KineSpring&reg; joint unloading implant: a case study

Successful two-stage revision of a KineSpring<sup>&reg;</sup> joint unloading implant: a case study

... joint preserving, unloading implant with potential to fill the therapeutic void between conservative and surgical knee OA treatments. The key component of the KineSpring System is a covered cobalt/cobalt-chrome ...

5

Preliminary results of an intravitreal dexamethasone implant (Ozurdex&reg;) in patients with persistent diabetic macular edema

Preliminary results of an intravitreal dexamethasone implant (Ozurdex<sup>&reg;</sup>) in patients with persistent diabetic macular edema

... dexamethasone implant, Ozurdex, shows efficacy for the treatment of DME, as both substantial improvements were registered in BCVA values, and signifi- cant reductions of CMT ...intravitreal implant.¹ The ...

6

Developments in administration of growth hormone treatment: focus on Norditropin&reg; Flexpro&reg;

Developments in administration of growth hormone treatment: focus on Norditropin<sup>&reg;</sup> Flexpro<sup>&reg;</sup>

... In this review, developments in the adminis- tration of growth hormone treatment for children and adults are discussed, with a particular focus on the most recently available pen devic[r] ...

8

Downregulation of CD44 reduces doxorubicin resistance of CD44+CD24- breast cancer cells

Downregulation of CD44 reduces doxorubicin resistance of CD44<sup>+</sup>CD24<sup>-</sup> breast cancer cells

... Cells verified as CD44 knockdown cells were treated with doxorubicin and compared with normal cells to confirm the role of CD44 in the breast cancer stem cell population.. Doxor[r] ...

8

The Effect of Implant Girth and Implant Collar on the Degree of Bone to Implant Contact and Bone Stresses in the Proximal Humerus

The Effect of Implant Girth and Implant Collar on the Degree of Bone to Implant Contact and Bone Stresses in the Proximal Humerus

... humeral implant models have markedly improved from older generations; though, some complications, such as implant loosening and proximal stress shielding, still occur with these newer implant designs ...

181

Tobramycin administered by the TOBI&reg; Podhaler&reg; for persons with cystic fibrosis: a review

Tobramycin administered by the TOBI<sup>&reg;</sup> Podhaler<sup>&reg;</sup> for persons with cystic fibrosis: a review

... A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multic[r] ...

10

Designing of CD8+ and CD8+-overlapped CD4+ epitope vaccine by targeting late and early proteins of human papillomavirus

Designing of CD8<sup>+</sup> and CD8<sup>+</sup>-overlapped CD4<sup>+</sup> epitope vaccine by targeting late and early proteins of human papillomavirus

... Time course and kinetics simulation prediction demonstrated the biological behavior of HPV45 in the presence of peptides where HPV45 interacts with different molecules, which play an [r] ...

19

Show all 8723 documents...

Related subjects